Linaclotide Safety and Efficacy in Pediatric Participants, 6 to 17 Years of Age, With Irritable Bowel Syndrome With Constipation (IBS-C) or Functional Constipation (FC)

NCT04026113 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Functional Constipation
Irritable Bowel Syndrome With Constipation

Interventions

DRUG: Linaclotide
DRUG: Placebo

Sponsor

AbbVie

Collaborators

[object Object]